Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

DMTX

DIMENSION THERAPEUTICS, INC. (DMTX)

Dimension Therapeutics, Inc.
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DMTX
DateHeureSourceTitreSymboleSociété
17/11/201722h07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:DMTXDimension Therapeutics, Inc.
14/11/201712h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DMTXDimension Therapeutics, Inc.
09/11/201723h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201717h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201716h24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201715h23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201715h17Edgar (US Regulatory)(25-NSE)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201715h15Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201714h57Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DMTXDimension Therapeutics, Inc.
07/11/201714h43GlobeNewswire Inc.Ultragenyx Completes Tender Offer and Acquisition of Dimension TherapeuticsNASDAQ:DMTXDimension Therapeutics, Inc.
06/11/201722h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DMTXDimension Therapeutics, Inc.
26/10/201714h30GlobeNewswire Inc.Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of DimensionNASDAQ:DMTXDimension Therapeutics, Inc.
13/10/201717h18PR Newswire (US)WEISSLAW LLP: Dimension Therapeutics, Inc. Acquisition May Not Be in the Best Interests of DMTX ShareholdersNASDAQ:DMTXDimension Therapeutics, Inc.
10/10/201714h45Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:DMTXDimension Therapeutics, Inc.
10/10/201714h34Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:DMTXDimension Therapeutics, Inc.
05/10/201721h48PR Newswire (US)Harwood Feffer LLP Announces Investigation of Dimension Therapeutics, Inc.NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201722h19Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201722h05Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201716h00PR Newswire (US)Dimension (DMTX) Alert: Johnson Fistel Investigates Proposed Sale of Dimension Therapeutics, Inc.; Are Shareholders Getting a...NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201714h50Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:DMTXDimension Therapeutics, Inc.
03/10/201714h30GlobeNewswire Inc.Ultragenyx to Acquire Dimension TherapeuticsNASDAQ:DMTXDimension Therapeutics, Inc.
02/10/201715h22GlobeNewswire Inc.Ultragenyx Comments on Dimension Therapeutics’ Announcement that Ultragenyx’s Offer is a “Superior Proposal” NASDAQ:DMTXDimension Therapeutics, Inc.
02/10/201715h16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DMTXDimension Therapeutics, Inc.
02/10/201714h30GlobeNewswire Inc.REGENXBIO Responds to Notification of a Superior Proposal Under Its Merger Agreement With Dimension TherapeuticsNASDAQ:DMTXDimension Therapeutics, Inc.
19/09/201714h00GlobeNewswire Inc.Dimension Board of Directors Determines Proposal from Ultragenyx Pharmaceutical Inc. Could Reasonably Be Expected to Lead to ...NASDAQ:DMTXDimension Therapeutics, Inc.
18/09/201721h10GlobeNewswire Inc.Dimension Confirms Receipt of Unsolicited Proposal from UltragenyxNASDAQ:DMTXDimension Therapeutics, Inc.
18/09/201714h35GlobeNewswire Inc.Ultragenyx Proposes to Acquire Dimension Therapeutics for $5.50 Per Share in CashNASDAQ:DMTXDimension Therapeutics, Inc.
05/09/201712h00PR Newswire (US)OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of DirectorsNASDAQ:DMTXDimension Therapeutics, Inc.
01/09/201700h23PR Newswire (US)SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Dimension Therapeutics, Inc. - DMTXNASDAQ:DMTXDimension Therapeutics, Inc.
31/08/201714h00GlobeNewswire Inc.Dimension Therapeutics Commences Patient Dosing in Global, Multi-Center Phase 1/2 Clinical Trial of DTX301 in Ornithine Trans...NASDAQ:DMTXDimension Therapeutics, Inc.
 Showing the most relevant articles for your search:NASDAQ:DMTX

Dernières Valeurs Consultées

Delayed Upgrade Clock